YAP1 and breast carcinoma: On the other hand, soft substrates activate RAP2 and LATS1/2 that retain YAP/TAZ in the cytoplasm of breast cancer cells, inhibiting the formation of aberrant acini, anchorage-independent growth, and xenograft growth [284].